These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 25786087)

  • 21. Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples.
    Dallol A; Buhmeida A; Al-Ahwal MS; Al-Maghrabi J; Bajouh O; Al-Khayyat S; Alam R; Abusanad A; Turki R; Elaimi A; Alhadrami HA; Abuzenadah M; Banni H; Al-Qahtani MH; Abuzenadah AM
    J Transl Med; 2016 May; 14(1):118. PubMed ID: 27146902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights.
    Dienstmann R; Elez E; Argiles G; Matos I; Sanz-Garcia E; Ortiz C; Macarulla T; Capdevila J; Alsina M; Sauri T; Verdaguer H; Vilaro M; Ruiz-Pace F; Viaplana C; Garcia A; Landolfi S; Palmer HG; Nuciforo P; Rodon J; Vivancos A; Tabernero J
    Mol Oncol; 2017 Sep; 11(9):1263-1272. PubMed ID: 28618197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-evolution of somatic variation in primary and metastatic colorectal cancer may expand biopsy indications in the molecular era.
    Kim R; Schell MJ; Teer JK; Greenawalt DM; Yang M; Yeatman TJ
    PLoS One; 2015; 10(5):e0126670. PubMed ID: 25974029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases.
    Paik PK; Shen R; Won H; Rekhtman N; Wang L; Sima CS; Arora A; Seshan V; Ladanyi M; Berger MF; Kris MG
    Cancer Discov; 2015 Jun; 5(6):610-21. PubMed ID: 25929848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study.
    Wish TA; Hyde AJ; Parfrey PS; Green JS; Younghusband HB; Simms MI; Fontaine DG; Dicks EL; Stuckless SN; Gallinger S; McLaughlin JR; Woods MO; Green RC
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1831-9. PubMed ID: 20570909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tropism between hepatic and pulmonary metastases in colorectal cancers.
    Kim SH; Choi SJ; Park JS; Lee J; Cho YB; Kang MW; Lee WY; Choi YS; Kim HK; Han J; Chun HK; Kim J
    Oncol Rep; 2012 Aug; 28(2):459-64. PubMed ID: 22664832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic biomarkers for metastatic colorectal cancer].
    Neumann JH
    Pathologe; 2016 Nov; 37(Suppl 2):180-185. PubMed ID: 27638531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 29. Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers.
    Lan YT; Jen-Kou L; Lin CH; Yang SH; Lin CC; Wang HS; Chen WS; Lin TC; Jiang JK; Chang SC
    J Surg Oncol; 2015 Jun; 111(7):905-10. PubMed ID: 25920435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Concordance of Genomic Profiles between Primary and Metastatic Colorectal Cancer.
    Lee SE; Park HY; Hwang DY; Han HS
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
    Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
    Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression.
    Oliveira C; Velho S; Moutinho C; Ferreira A; Preto A; Domingo E; Capelinha AF; Duval A; Hamelin R; Machado JC; Schwartz S; Carneiro F; Seruca R
    Oncogene; 2007 Jan; 26(1):158-63. PubMed ID: 16953233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. There is no increase in frequency of somatic mutations in metastases compared with primary colorectal carcinomas with microsatellite instability.
    Barnetson R; Eckstein R; Robinson B; Schnitzler M
    Genes Chromosomes Cancer; 2003 Oct; 38(2):149-56. PubMed ID: 12939742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.
    Tabone T; Abuhusain HJ; Nowak AK; ; Erber WN; McDonald KL
    J Clin Pathol; 2014 Jul; 67(7):550-5. PubMed ID: 24695838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases.
    Haddad R; Ogilvie RT; Croitoru M; Muniz V; Gryfe R; Pollet A; Shanmugathasan P; Fitzgerald T; Law CH; Hanna SS; Jothy S; Redston M; Gallinger S; Smith AJ
    Ann Surg Oncol; 2004 Nov; 11(11):977-82. PubMed ID: 15525826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RAS, BRAF, and TP53 gene mutations in Taiwanese colorectal cancer patients.
    Chang YS; Chang SJ; Yeh KT; Lin TH; Chang JG
    Onkologie; 2013; 36(12):719-24. PubMed ID: 24356563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
    Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
    Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-depth sequencing of over 750 genes supports linear progression of primary tumors and metastases in most patients with liver-limited metastatic colorectal cancer.
    Tan IB; Malik S; Ramnarayanan K; McPherson JR; Ho DL; Suzuki Y; Ng SB; Yan S; Lim KH; Koh D; Hoe CM; Chan CY; Ten R; Goh BK; Chung AY; Tan J; Chan CX; Tay ST; Alexander L; Nagarajan N; Hillmer AM; Tang CL; Chua C; Teh BT; Rozen S; Tan P
    Genome Biol; 2015 Feb; 16(1):32. PubMed ID: 25808843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers.
    Orjuela S; Menigatti M; Schraml P; Kambakamba P; Robinson MD; Marra G
    BMC Cancer; 2020 Apr; 20(1):290. PubMed ID: 32252665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.